Institute of Clinical Research at Krankenhaus Nordwest, University Cancer Center Frankfurt
Prof. Salah-Eddin Al-Batran is current Director of the Institute of Clinical Cancer Research, a joint foundation of the University Cancer Center (UCT), Frankfurt and Northwest Hospital in Frankfurt. He is also Head of Gastrointestinal Cancer Center at the Northwest Hospital. Prof. Al-Batran is Member of the Board of Directors of the University Cancer Center, a German Cancer Aid (Krebshilfe) certified Comprehensive Cancer Center (CCC) of Excellence. Prof. Al-Batran is board-certified Hematologist and Oncologist. Further experiences include Internal Medicine (board-certified), Palliative Medicine (board-certified), and Pain Management (board certified). He received his medical degree from the Ludwig-Maximilian-University in Munich. After the completion of an internship and residency in internal medicine, Prof. Al-Batran completed fellowships in Hematology and Oncology, in Frankfurt. Since 2014, he is full professor (APL) at the Goethe-University of Frankfurt. Prof. Al-Batran is an internationally recognized clinical researcher and expert in the field of Gastrointestinal Cancer. His clinical research interest has been particularly focused on esophageal and gastric cancer. Prof. Al-Batran is Founder and Chair of Garman Gastric Group at AIO (Formally Study FLOT group). He is designated Investigator of the German Consortium for Translational Research (DKTK) and several other organizations. Prof. Al-Batran is teacher of Internal Medicine at the Goethe-University of Frankfurt. He has given numerous lectures at national and international symposia and conferences including several oral presentations and late-breaking abstracts. Prof. Al-Batran’s vision is to cure locally advanced or metastatic cancer by integrating immunotherapy and precision medicine into multimodality therapy of localized and oligometastatic cancer.
Thursday, 4 July
10:30 – 10:45